These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17444846)

  • 21. Association between postprandial LDL conjugated dienes and the severity of liver fibrosis in NASH.
    Musso G; Cassader M; Gambino R; Durazzo M; Pagano G
    Hepatology; 2006 May; 43(5):1169-70. PubMed ID: 16628638
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of peroxisome proliferator activated receptor alpha in the pathogenesis of nonalcoholic steatohepatitis].
    Zhao CY; Deng ZJ; Zhou JY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):146-7. PubMed ID: 16494792
    [No Abstract]   [Full Text] [Related]  

  • 23. Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production.
    Toda K; Kumagai N; Kaneko F; Tsunematsu S; Tsuchimoto K; Saito H; Hibi T
    J Gastroenterol Hepatol; 2009 May; 24(5):860-5. PubMed ID: 19220679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipodystrophy of the liver and steroid treatment of chronic liver diseases].
    Nicolaescu T; Bordeianu A; Bittman E; Dragulescu N
    Rev Int Hepatol; 1967; 17(4):367-76. PubMed ID: 6048616
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease.
    Manco M; Marcellini M; Giannone G; Nobili V
    Am J Clin Pathol; 2007 Jun; 127(6):954-60. PubMed ID: 17509993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Increase of appetite by Nuran in liver diseases].
    Hilt G; Bungeroth KA
    Munch Med Wochenschr; 1971 Jan; 113(3):91-4. PubMed ID: 5276193
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sirepar on experimental cirrhosis in rats.
    Szarvas F; Biliczki F
    Ther Hung; 1970; 18(3):103-6. PubMed ID: 5496809
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment for NASH: the value of histology.
    Elitsur Y; Lawrence Z; Wang R; Durst PR
    Am J Gastroenterol; 2005 Jan; 100(1):250-1. PubMed ID: 15654810
    [No Abstract]   [Full Text] [Related]  

  • 29. Silybin-phosphatidylcholine complex. Monograph.
    Altern Med Rev; 2009 Dec; 14(4):385-90. PubMed ID: 20030465
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.
    Hashem RM; Mahmoud MF; El-Moselhy MA; Soliman HM
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):995-1001. PubMed ID: 18787467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 32. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis.
    Torer N; Ozenirler S; Yucel A; Bukan N; Erdem O
    Scand J Gastroenterol; 2007 Sep; 42(9):1095-101. PubMed ID: 17710676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology.
    Ahmed MH
    Scand J Gastroenterol; 2005 Oct; 40(10):1260. PubMed ID: 16165706
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonalcoholic steatohepatitis.
    Williams CN
    Can J Gastroenterol; 1999 Oct; 13(8):639-40. PubMed ID: 10545649
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preventive and therapeutic actions of glycyrrhizin, glycyrrhetic acid and crude saikosides on experimental liver cirrhosis in rats].
    Zhao MQ; Han DW; Ma XH; Zhao YC; Yin L; Li CM
    Yao Xue Xue Bao; 1983 May; 18(5):325-31. PubMed ID: 6637483
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
    Marra F; Gastaldelli A; Svegliati Baroni G; Tell G; Tiribelli C
    Trends Mol Med; 2008 Feb; 14(2):72-81. PubMed ID: 18218340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Necrosis in alcoholic hepatopathies].
    Enríquez L; Díaz-Rubio García M; Zamarrón A; Díaz-Rubio M
    Rev Esp Enferm Apar Dig; 1972 Jun; 37(6):679-702. PubMed ID: 5048000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.